Abstract
Whole-cell antibacterial assays are particularly suitable for fast detection and semi-quantification of bioactivities in extracts or other solutions such as microbial culture supernatants. As Actinomycetales, including the members of the genus Streptomyces, are one of the most potent “suppliers” of antibiotics and other bioactive compounds, there is a strong interest in the development of useful assays enabling early identification of such valuable producers. Furthermore, such assays facilitate the screening of a large collection of clones for the detection of engineered “super-producers” that are essential for industrial manufacturing of the respective product.
In this protocol, we describe a whole-cell assay for a fast detection of antimicrobial agents in culture supernatants. As model, Streptomyces fradiae DSM 41546, the producer of the antibiotic tylosin, and the test strain Bacillus subtilis ATCC 6051 are used. Culture supernatants of S. fradiae DSM 41546 and controls are diluted, and their antibiotic activity is tested against B. subtilis ATCC 6051. For the dilutions of tylosin-containing culture supernatant, a clear concentration-dependent growth inhibition effect on B. subtilis ATCC 6051 is demonstrated. In contrast, dilutions of the culture supernatant lacking tylosin do not inhibit the growth of B. subtilis. Moreover, including defined concentrations of tylosin facilitates the semi-quantification of tylosin in the culture supernatants.
Our results confirm the applicability of the assay in fast screenings for antimicrobial products in culture supernatants. The protocol can be used as positive control within screening campaigns in the drug discovery field.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Robertsen HL, Musiol-Kroll EM (2019) Actinomycete-derived polyketides as a source of antibiotics and lead structures for the development of new antimicrobial drugs. J Antibiot 8(4):157
Ravishankar VR, Jamuna AB (eds) (2022) Natural products from Actinomycetes: diversity, ecology and drug discovery. Springer, Singapore
Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200–216
World Health Organization. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 05 Jan 2022
Liao J, Xu G, Mevers EE, Clardy J, Watnick PI (2018) A high-throughput, whole cell assay to identify compounds active against carbapenem-resistant Klebsiella pneumoniae. PLoS One 13(12):e0209389
Balouiri M, Sadiki M, Ibnsouda SK (2016) Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal 6(2):71–79
Nybond S, Karp M, Yrjönen T, Tammela P (2015) Bioluminescent whole-cell reporter gene assays as screening tools in the identification of antimicrobial natural product extracts. J Microbiol Methods 114:54–56
Vinuesa MA, Fernandez A (2021) A simple antifungal assay for testing actinomycetes and other microbial extracts. Methods Mol Biol 2296:217–225
McGuire JM, Boniece WS, Higgens CE, Hoehn MM, Stark WM, Westhead J, Wolfe RN (1961) Tylosin, a new antibiotic: I. Microbiological studies. Antibiot Chemother 11(5):320–327
Hamill RL, Haney ME Jr, Stamper M, Wlley PF (1961) Tylosin, a new antibiotic: II. Isolation, properties, and preparation of pesmycosin, a microbiologically active degradation product. Antibiot Chemother 11 (5):328-334
Omura S, Inokoshi J, Matsubara H, Tanaka H (1983) Ribosome-binding activities and antimicrobial activities of tylosin and its related compounds. J Antibiot 36(12):1709–1712
Gingerich DA, Baggot JD, Kowalski JJ (1977) Tylosin antimicrobial activity and pharmacokinetics in cows. Can Vet J 18(4):96
Tsuchiya M, Hamada M, Takeuchi T, Umezawa H, Yamamoto K, Tanaka H, Kiyoshima K, Mori S, Okamoto R (1982) Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships. J Antibiot 35(6):661–672
Ose EE, Tonkinson LV (1985) Comparison of the antimycoplasma activity of two commercially available tylosin premixes. Poult Sci J 64(2):287–293
American Type Culture Collection (ATCC). https://www.atcc.org/products/6051. Accessed 27 Jan 2022
Bacterial Diversity (BacDive), Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ). https://bacdive.dsmz.de/strain/15193. Accessed 27 Jan 2022
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rütten, A., Wohlleben, W., Mitousis, L., Musiol-Kroll, E.M. (2023). A Whole-Cell Assay for Detection of Antibacterial Activity in Actinomycete Culture Supernatants. In: Sass, P. (eds) Antibiotics. Methods in Molecular Biology, vol 2601. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2855-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2855-3_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2854-6
Online ISBN: 978-1-0716-2855-3
eBook Packages: Springer Protocols